AAAAAA
Results:
1-7
|
Results: 7
Authors:
Vriesendorp, HM
Citation: Hm. Vriesendorp, Of scientific physicians and evidence-based medicine: In regard to Glatstein, INT J RAD O, 51(1), 2001, pp. 280-281
Authors:
Vriesendorp, HM
Quadri, SM
Citation: Hm. Vriesendorp et Sm. Quadri, Radiolabeled immunoglobulin therapy in patients with Hodgkin's disease, CANC BIO R, 15(5), 2000, pp. 431-445
Authors:
Borchardt, PE
Quadri, SM
Freedman, RS
Vriesendorp, HM
Citation: Pe. Borchardt et al., Intraperitoneal radioimmunotherapy with human monoclonal IGM in nude mice with peritoneal carcinomatosis, CANC BIO R, 15(1), 2000, pp. 53-64
Authors:
Lai, J
Quadri, SM
Borchardt, PE
Harris, L
Wucher, R
Askew, E
Schweichler, L
Vriesendorp, HM
Citation: J. Lai et al., Pharmacokinetics of radiolabeled polyclonal antiferritin in patients with Hodgkin's disease, CLIN CANC R, 5(10), 1999, pp. 3315S-3323S
Authors:
Vriesendorp, HM
Quadri, SM
Wyllie, CT
Lai, J
Borchardt, PE
Harris, L
Wucher, R
Askew, E
Schweichler, L
Citation: Hm. Vriesendorp et al., Fractionated radiolabeled antiferritin therapy for patients with recurrentHodgkin's disease, CLIN CANC R, 5(10), 1999, pp. 3324S-3329S
Authors:
Van Bekkum, DW
Vriesendorp, HM
Citation: Dw. Van Bekkum et Hm. Vriesendorp, Hematopoietic stem-cell transplantation for acute leukemia, N ENG J MED, 340(10), 1999, pp. 809-810
Authors:
Quadri, SM
Vriesendorp, HM
Citation: Sm. Quadri et Hm. Vriesendorp, Effects of linker chemistry on the pharmacokinetics of radioimmunoconjugates, Q J NUCL M, 42(4), 1998, pp. 250-261
Risultati:
1-7
|